Lose Weight

Prescription GLP-1 receptor agonist medications in the semaglutide and tirzepatide class have strong clinical trial evidence supporting their effectiveness for weight loss. Most over-the-counter diet pills and weight-loss supplements lack strong clinical evidence. Your results depend on the specific medication, your dose, and your adherence, which you should discuss directly with a physician. You can review how these protocols work in our guide to semaglutide for weight loss.

Coverage for prescription weight loss medication varies widely by insurer, and many commercial health plans exclude weight-management drugs entirely. When an insurer does offer coverage, approval typically requires a prescriber to document that a patient meets specific clinical criteria. Medicare and Medicaid follow this same general exclusion for weight-management drugs, with coverage decided plan by plan rather than guaranteed. Opt Health is a self-pay membership and does not bill insurance directly, though members can use HSA or FSA funds for clinical services. Prescriptions filled separately at an outside pharmacy depend on your individual policy for any reimbursement. See our guide to GLP-1 cost for a detailed breakdown of coverage rules and self-pay pricing.

The most effective weight loss strategy for men over 40 pairs nutrition and activity adjustments with a clinical evaluation of underlying hormone and metabolic health. A slowing metabolic rate and a gradual decline in testosterone commonly occur after 40, making weight management harder than it was at a younger age. For some men, stalled progress is driven by the visceral-fat and testosterone loop outlined on this page. Addressing an underlying hormonal factor alongside diet, activity, and clinically appropriate prescription medication such as a GLP-1 is more likely to work than diet or exercise changes alone. A physician must evaluate these hormonal markers, as they cannot be accurately self-diagnosed.

Medically supervised care begins with diagnostic lab work and a physician consultation to identify contributing biological factors, such as the connection between visceral fat and testosterone. When clinically appropriate, a physician can add prescription medications like a GLP-1 to your plan. Diet and exercise modifications alone do not include regular laboratory testing, clinical oversight, or access to prescription therapies. Follow-up blood panels allow your doctor to adjust your medication dose and care plan based on how your biomarkers respond over time.

The most common side effects of GLP-1 receptor agonist medications involve the gastrointestinal system, specifically nausea, vomiting, diarrhea, and constipation, alongside an association with gallbladder disease and gallstones. Their FDA labeling includes a boxed warning regarding thyroid C-cell tumors observed in rodent studies, which contraindicates their use if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Rapid weight reduction can also affect lean tissue and follicle cycling, which we address in our guide to protecting lean mass on GLP-1 and our clinical resource on hair loss. An Opt Health physician reviews your complete health and family history for these specific risk factors before prescribing any medication and monitors your symptoms throughout ongoing care.

Current FDA prescribing labeling for GLP-1 receptor agonist weight loss medications states that they are not recommended during pregnancy, and labeling also advises against their use while breastfeeding. A physician evaluates pregnancy plans and breastfeeding status as part of your medical history before prescribing, establishing appropriate clinical timing for starting or stopping treatment. You should discuss your specific timeline and family planning directly with your doctor rather than making decisions about starting or stopping medication on your own.

Prescription GLP-1 injections carry a stronger clinical trial evidence base for weight loss than oral weight-loss pills and supplements. In published comparisons, bariatric surgery generally produces larger average total body weight loss than medication alone, though surgical intervention carries procedure risks and recovery requirements that medication does not involve. Which approach fits best depends on a physician’s evaluation of your health profile, prior treatment history, and specific goals rather than a universal ranking.

Every FDA-approved GLP-1 weight loss injection requires a prescription from a licensed physician, and no legitimate over-the-counter injectable version exists. An Opt Health physician reviews your lab work and medical history at your initial consultation before deciding whether medications like semaglutide or tirzepatide are clinically appropriate. The term GLP-1 stands for glucagon-like peptide-1, a hormone the body naturally produces that these medications target or mimic through its receptor. There is no FDA-approved GLP-2 or GLP-3 weight-loss medication class, as those terms represent a common naming confusion.

Whether GLP-1 and GIP medications like tirzepatide (Zepbound) or semaglutide (Wegovy) directly cause insomnia is not clearly established, and sleep disruptions reported by patients are more plausibly linked to gastrointestinal side effects like nausea or reflux that worsens when lying down. In contrast, the 2024 SURMOUNT-OSA trials published in the New England Journal of Medicine found that tirzepatide significantly reduced obstructive sleep apnea severity, measured by the apnea-hypopnea index, in adults with obesity and moderate-to-severe OSA. Roughly half of participants at the highest dose met criteria for disease resolution alongside improved sleep-related quality of life. If your sleep disruption is unrelated to weight-loss medication or sleep apnea, review the guide on trouble sleeping to discuss other potential causes with your physician.